- €60.99m
- €140.59m
- €109.11m
Annual income statement for Talenom, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | C2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 82.8 | 102 | 122 | 106 | 109 |
| Cost of Revenue | |||||
| Gross Profit | 79.8 | 98.2 | 118 | 105 | 108 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 68 | 86.8 | 114 | 98.7 | 103 |
| Operating Profit | 14.8 | 15.3 | 7.95 | 7.05 | 6.18 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 14 | 14.6 | 4.26 | 2.54 | 2.42 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 10.8 | 11.8 | 3.36 | 2.72 | 2.86 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 10.8 | 11.8 | 3.36 | 6.09 | 0.464 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 10.8 | 11.8 | 3.36 | 6.09 | 0.464 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.274 | 0.296 | 0.161 | 0.079 | 0.095 |
| Dividends per Share |